-
Mashup Score: 6
A recent study from the laboratory of Shi-Yuan Cheng, PhD, has identified novel mechanisms underlying RNA splicing events within glioma tumor cells, mechanisms which may serve as novel therapeutic targets, according to findings published in The Journal of Clinical Investigation.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Leading Prostate Cancer Research for More than 20 Years - 8 month(s) ago
Prostate cancer is the most common type of cancer in men and is currently the second-leading cause of death in men in the U.S. In 2001, the National Cancer Institute established seven Specialized Programs of Research Excellence (SPORE) in prostate cancer across the U.S., one of which includes the Robert H. Lurie Comprehensive Cancer Center of Northwestern University’s Prostate Cancer SPORE.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
The goal of @LurieCancer’s #ProstateCancer SPORE, led by @SarkiAbdulkadi1 and Maha Hussain, MD, is to advance translational research across the bench and bedside, including clinical trials that aim to improve outcomes and quality of life. https://t.co/qgQg5LcK5D via… https://t.co/RLnA7VResb
-
-
Mashup Score: 5
A multi-institutional team of investigators has discovered that targeting a specific protein interaction within immunosuppressive breast cancer cells may increase antitumor immune responses, according to findings published in the Journal of Clinical Investigation.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
A novel strategy for targeting immunosuppressive #breastcancer cells may promote antitumor immunity in #TNBC and slow progression, according to findings from Lurie Cancer Center's @BinZhang_NU in @jclinicalinvest. https://t.co/ZRTroE2D2D #BCSM
-
-
Mashup Score: 3Cancer Drug Trial Provides Lessons for Future - 8 month(s) ago
A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal surgery, according to a clinical trial published in the Journal of Clinical Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
A clinical trial and quality-of-life questionnaire offer important insights about what's "a meaningful difference to patients," said @LurieCancer's David Cella, PhD, co-author of the study in @JCO_ASCO. https://t.co/yp9cqPKMvo via @NUFeinbergMed #QoL #kidneycancer
-
-
Mashup Score: 0Potential Therapeutic Target for Small Cell Lung Cancer Discovered - 9 month(s) ago
Northwestern Medicine investigators have discovered that inhibiting a chromatin remodeling complex associated with a particular gene in small-cell lung cancer cells may decrease cancer cell differentiation and tumor growth, according to findings published in Nature Communications.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
A study led by @LurieCancer's @LuWangLab and @zhao_zibo in @NatureComms suggests that inhibiting a chromatin remodeling complex associated with a particular gene in small-cell #lungcancer may serve as a promising therapeutic target for #SCLC. https://t.co/5V1YaO2QHZ #LCSM
-
-
Mashup Score: 13Novel Mechanism Supports Antitumor Response and T-cell Survival - 9 month(s) ago
A recent Northwestern Medicine study has discovered a previously unknown molecular mechanism that supports antitumor responses and cell survival in cytotoxic immune cells, according to findings published in the Journal of Clinical Investigation.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
A previously unknown molecular mechanism supports antitumor responses and T-cell survival, according to a recent study from Bin Zhang, MD, PhD, of @LurieCancer @NUFeinbergMed, published in @jclinicalinvest. https://t.co/KSBc4LVO6P @NorthwesternMed #immunotherapy
-
-
Mashup Score: 34
Mercedes Carnethon, PhD, vice chair and Mary Harris Thompson Professor of Preventive Medicine and co-chair of the Appointments, Promotions, and Tenure Committee at Northwestern University Feinberg School of Medicine, has been named chair of the Department of Preventive Medicine, effective September 1.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Hem/OncsTweet-
Congratulations to @MCarnethon for being named Chair of Preventive Medicine @NUFeinbergMed ! https://t.co/bq9QfgCWfa
-
-
Mashup Score: 6
Northwestern scientists have developed a new soft, flexible, battery-free implant that allows patients and physicians to monitor bladder fullness in real time.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
A new implantable sensor and app developed by Lurie Cancer Center member @ProfJohnARogers and collaborators at @NorthwesternU is a potential game-changer for people with #bladdercancer, paralysis or spina bifida. https://t.co/EsWncWyJWR via @NUFeinbergMed #blcsm
-
-
Mashup Score: 30Novel Role for Metabolites in Cellular Metabolism Discovered - 9 month(s) ago
Investigators led by Issam Ben-Sahra, PhD, have discovered how cellular metabolism fluctuates in response to changes in levels of pyrimidines, metabolites used by cells to make DNA and RNA, according to a recent study published in Science.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Hem/OncsTweet-
Amazing work by @LurieCancer Center's @bensahralab just published in @ScienceMagazine on how pyrimidines maintain mitochondrial pyruvate oxidation. https://t.co/KpBFMuNIYO
-
-
Mashup Score: 6Predicting Infection Risk in Childhood Cancer - 9 month(s) ago
A model can accurately predict the risk of bloodstream infections in a subset of children with cancer, according to a study published in the Journal of Clinical Oncology.
Source: news.feinberg.northwestern.eduCategories: General Medicine News, Onc News and JournalsTweet-
For children with cancer, fever is a common complication. A statistical model can predict the risk of bloodstream infections and could reduce unnecessary antibiotic use, per findings from @LurieCancer's Jenna Rossoff, MD, and collaborators in @JCO_ASCO https://t.co/d5LPszQZ4i
-
Novel genetic mechanisms within #glioma tumor cells may serve as novel therapeutic targets, according to a recent study from the laboratory of @LurieCancer’s Shi-Yuan Cheng, PhD, published in @jclinicalinvest. https://t.co/0YIR5fOGwv via @NUFeinbergMed #immunotherapy #BTAM